![A comprehensive evaluation of the enzymatic and nonenzymatic antioxidant systems in childhood asthma - Journal of Allergy and Clinical Immunology A comprehensive evaluation of the enzymatic and nonenzymatic antioxidant systems in childhood asthma - Journal of Allergy and Clinical Immunology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/20074945-9269-46de-86fb-950368623d98/gr4_lrg.jpg)
A comprehensive evaluation of the enzymatic and nonenzymatic antioxidant systems in childhood asthma - Journal of Allergy and Clinical Immunology
![Pyrrolobenzodiazepine Dimer Antibody–Drug Conjugates: Synthesis and Evaluation of Noncleavable Drug-Linkers | Journal of Medicinal Chemistry Pyrrolobenzodiazepine Dimer Antibody–Drug Conjugates: Synthesis and Evaluation of Noncleavable Drug-Linkers | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/acs.jmedchem.7b00736/asset/images/large/jm-2017-00736q_0003.jpeg)
Pyrrolobenzodiazepine Dimer Antibody–Drug Conjugates: Synthesis and Evaluation of Noncleavable Drug-Linkers | Journal of Medicinal Chemistry
![Metabolic Disposition of Lurbinectedin, a Potent Selective Inhibitor of Active Transcription of Protein-Coding Genes, in Nonclinical Species and Patients | Drug Metabolism & Disposition Metabolic Disposition of Lurbinectedin, a Potent Selective Inhibitor of Active Transcription of Protein-Coding Genes, in Nonclinical Species and Patients | Drug Metabolism & Disposition](https://dmd.aspetjournals.org/sites/default/files/styles/medium/public/highwire/dmd/50/4.cover-source.jpg?itok=zrZpiwe1)
Metabolic Disposition of Lurbinectedin, a Potent Selective Inhibitor of Active Transcription of Protein-Coding Genes, in Nonclinical Species and Patients | Drug Metabolism & Disposition
![Metabolic Disposition of Lurbinectedin, a Potent Selective Inhibitor of Active Transcription of Protein-Coding Genes, in Nonclinical Species and Patients | Drug Metabolism & Disposition Metabolic Disposition of Lurbinectedin, a Potent Selective Inhibitor of Active Transcription of Protein-Coding Genes, in Nonclinical Species and Patients | Drug Metabolism & Disposition](https://dmd.aspetjournals.org/content/dmd/50/4/327/F1.large.jpg)
Metabolic Disposition of Lurbinectedin, a Potent Selective Inhibitor of Active Transcription of Protein-Coding Genes, in Nonclinical Species and Patients | Drug Metabolism & Disposition
![Pyrrolobenzodiazepine Dimer Antibody–Drug Conjugates: Synthesis and Evaluation of Noncleavable Drug-Linkers | Journal of Medicinal Chemistry Pyrrolobenzodiazepine Dimer Antibody–Drug Conjugates: Synthesis and Evaluation of Noncleavable Drug-Linkers | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/acs.jmedchem.7b00736/asset/images/large/jm-2017-00736q_0012.jpeg)
Pyrrolobenzodiazepine Dimer Antibody–Drug Conjugates: Synthesis and Evaluation of Noncleavable Drug-Linkers | Journal of Medicinal Chemistry
![JCM | Free Full-Text | Hepatobiliary Complications in Children with Sickle Cell Disease: A Retrospective Review of Medical Records from 616 Patients JCM | Free Full-Text | Hepatobiliary Complications in Children with Sickle Cell Disease: A Retrospective Review of Medical Records from 616 Patients](https://www.mdpi.com/jcm/jcm-08-01481/article_deploy/html/images/jcm-08-01481-g004.png)
JCM | Free Full-Text | Hepatobiliary Complications in Children with Sickle Cell Disease: A Retrospective Review of Medical Records from 616 Patients
![Metabolic Disposition of Lurbinectedin, a Potent Selective Inhibitor of Active Transcription of Protein-Coding Genes, in Nonclinical Species and Patients | Drug Metabolism & Disposition Metabolic Disposition of Lurbinectedin, a Potent Selective Inhibitor of Active Transcription of Protein-Coding Genes, in Nonclinical Species and Patients | Drug Metabolism & Disposition](https://dmd.aspetjournals.org/content/dmd/50/4/327/F6.large.jpg)
Metabolic Disposition of Lurbinectedin, a Potent Selective Inhibitor of Active Transcription of Protein-Coding Genes, in Nonclinical Species and Patients | Drug Metabolism & Disposition
![Metabolic Disposition of Lurbinectedin, a Potent Selective Inhibitor of Active Transcription of Protein-Coding Genes, in Nonclinical Species and Patients | Drug Metabolism & Disposition Metabolic Disposition of Lurbinectedin, a Potent Selective Inhibitor of Active Transcription of Protein-Coding Genes, in Nonclinical Species and Patients | Drug Metabolism & Disposition](https://dmd.aspetjournals.org/content/dmd/50/4/327/F5.large.jpg)
Metabolic Disposition of Lurbinectedin, a Potent Selective Inhibitor of Active Transcription of Protein-Coding Genes, in Nonclinical Species and Patients | Drug Metabolism & Disposition
![Metabolic Disposition of Lurbinectedin, a Potent Selective Inhibitor of Active Transcription of Protein-Coding Genes, in Nonclinical Species and Patients | Drug Metabolism & Disposition Metabolic Disposition of Lurbinectedin, a Potent Selective Inhibitor of Active Transcription of Protein-Coding Genes, in Nonclinical Species and Patients | Drug Metabolism & Disposition](https://dmd.aspetjournals.org/content/dmd/50/4/327/F2.large.jpg)
Metabolic Disposition of Lurbinectedin, a Potent Selective Inhibitor of Active Transcription of Protein-Coding Genes, in Nonclinical Species and Patients | Drug Metabolism & Disposition
![JCM | Free Full-Text | Hepatobiliary Complications in Children with Sickle Cell Disease: A Retrospective Review of Medical Records from 616 Patients JCM | Free Full-Text | Hepatobiliary Complications in Children with Sickle Cell Disease: A Retrospective Review of Medical Records from 616 Patients](https://www.mdpi.com/jcm/jcm-08-01481/article_deploy/html/images/jcm-08-01481-g001.png)